Kulics J, Rajnavölgyi E, László G, Gergely J
Immunol Lett. 1986 Jun;12(5-6):321-7. doi: 10.1016/0165-2478(86)90037-4.
Intravenous injection of human IgG Fc fragments in mice resulted in the stimulation or inhibition of an oxazolone-specific antibody response depending on the schedule of Fc fragment injection. High and low responder mice for oxazolone were injected with Fc fragments according to two protocols: either on the day of oxazolone priming, or together with the oxazolone boost, and the isotype composition of oxazolone-specific antibodies was analysed by solid phase radioimmunoassay. We found the primary and secondary anti-oxazolone IgM levels increased in all instances, irrespective of the schedule of Fc fragment treatment. In contrast, the oxazolone-specific IgG production was increased only if Fc fragments were injected at the time of antigen priming. Injection of Fc fragments together with a secondary injection of oxazolone resulted in the inhibition of oxazolone-specific IgG production. Both stimulation and inhibition of oxazolone-specific antibodies were more pronounced in the low responder C57BL/6 mice strain.
给小鼠静脉注射人IgG Fc片段,根据Fc片段注射方案的不同,会刺激或抑制恶唑酮特异性抗体反应。根据两种方案给恶唑酮高反应和低反应小鼠注射Fc片段:要么在恶唑酮初次免疫当天注射,要么与恶唑酮加强免疫一起注射,并用固相放射免疫测定法分析恶唑酮特异性抗体的同种型组成。我们发现,无论Fc片段治疗方案如何,所有情况下初次和二次抗恶唑酮IgM水平均升高。相比之下,只有在抗原初次免疫时注射Fc片段,恶唑酮特异性IgG的产生才会增加。将Fc片段与恶唑酮二次注射一起注射会导致恶唑酮特异性IgG产生受到抑制。恶唑酮特异性抗体的刺激和抑制在低反应性C57BL/6小鼠品系中更为明显。